The modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is approved in several countries for the prevention of mpox and smallpox in adults, but insufficient data are available to support ...

Vaccines currently available to the global market are Bavarian Nordic’s MVA-BN (JYNNEOS), KM Biologics’ LC16, and Emergent ...

One dose of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; Jynneos) mpox vaccine was moderately effective in preventing mpox infections, according to a Canadian observational, emulated ...

Today's health news includes what RFK Jr. can do on vaccines, escaped monkeys, and who know in the Make America Healthy Again ...

Clinical study in children 2-11 years of age follows the recent EMA and WHO approvals of the MVA-BN mpox vaccine for ...

Both organizations have made concerted efforts to help countries acquire vaccines amid ongoing outbreaks. WHO added the ...

This research could expand access to Bavarian Nordic’s MVA-BN mpox vaccine, currently the only WHO prequalified vaccine for healthy adults and adolescents, to include these vulnerable populations.

Receiving a single dose of one type of smallpox vaccine seems to lower the risk of catching mpox by around 60 per cent, ...

The announcement came on the heels of the arrival of the first MVA-BN vaccines to the Democratic Republic of Congo (DRC), the epicentre of the epidemic. "This first prequalification of a vaccine ...

There are two vaccines approved against mpox, MVA-BN and LC16. These jabs are based on weakened versions of orthopoxviral and ...

Regardless of 1 or 2 doses, mpox antibodies wane by 6 to 12 months. HealthDay News — Immunity against mpox may be waning for those vaccinated with the modified vaccinia Ankara-Bavarian Nordic ...

The modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is approved in several countries for the prevention of mpox and smallpox in adults, but insufficient data are available to support ...